These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 32281563

  • 1. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
    Hou H, Yang W, Bao S, Cao Y.
    J Oleo Sci; 2020 May 02; 69(5):479-486. PubMed ID: 32281563
    [Abstract] [Full Text] [Related]

  • 2. Epigallocatechin gallate improves insulin signaling by decreasing toll-like receptor 4 (TLR4) activity in adipose tissues of high-fat diet rats.
    Bao S, Cao Y, Fan C, Fan Y, Bai S, Teng W, Shan Z.
    Mol Nutr Food Res; 2014 Apr 02; 58(4):677-86. PubMed ID: 24259392
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB, Carvalho-Silva M, Gomes LM, Okuda MH, Santana AA, Streck EL, Seelaender M, do Nascimento CM, Ribeiro EB, Lira FS, Oyama LM.
    J Nutr Biochem; 2015 Nov 02; 26(11):1348-56. PubMed ID: 26300331
    [Abstract] [Full Text] [Related]

  • 5. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
    Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TY, Fung ML, Tipoe GL.
    Eur J Nutr; 2014 Feb 02; 53(1):187-99. PubMed ID: 23515587
    [Abstract] [Full Text] [Related]

  • 6. Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes.
    Bao S, Cao Y, Zhou H, Sun X, Shan Z, Teng W.
    J Agric Food Chem; 2015 Mar 18; 63(10):2811-9. PubMed ID: 25732404
    [Abstract] [Full Text] [Related]

  • 7. [Effect of Berberine on the Insulin Resistance and TLR4/IKKbeta/NF-kappaB Signaling Pathways in Skeletal Muscle of Obese Rats with Insulin Resistance].
    Zhang DS, Bai XH, Yao YJ, Mu DZ, Chen J.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov 18; 46(6):827-31. PubMed ID: 26867315
    [Abstract] [Full Text] [Related]

  • 8. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
    Santana A, Santamarina A, Souza G, Mennitti L, Okuda M, Venancio D, Seelaender M, do Nascimento CO, Ribeiro E, Lira F, Oyama L.
    J Nutr Biochem; 2015 Sep 18; 26(9):893-902. PubMed ID: 26048201
    [Abstract] [Full Text] [Related]

  • 9. Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction.
    Jang HJ, Ridgeway SD, Kim JA.
    Am J Physiol Endocrinol Metab; 2013 Dec 18; 305(12):E1444-51. PubMed ID: 24148349
    [Abstract] [Full Text] [Related]

  • 10. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L, Meng ZJ, Xiong RB, Guo JQ, Lu XC, Zheng ZW, Deng YP, Luo BD, Zou F, Li H.
    Acta Pharmacol Sin; 2015 May 18; 36(5):597-605. PubMed ID: 25891086
    [Abstract] [Full Text] [Related]

  • 11. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.
    Dey P, Olmstead BD, Sasaki GY, Vodovotz Y, Yu Z, Bruno RS.
    J Nutr Biochem; 2020 Oct 18; 84():108455. PubMed ID: 32688217
    [Abstract] [Full Text] [Related]

  • 12. Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
    Bae UJ, Park J, Park IW, Chae BM, Oh MR, Jung SJ, Ryu GS, Chae SW, Park BH.
    Am J Chin Med; 2018 Oct 18; 46(3):617-632. PubMed ID: 29595075
    [Abstract] [Full Text] [Related]

  • 13. Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity.
    Sampath C, Rashid MR, Sang S, Ahmedna M.
    Biomed Pharmacother; 2017 Mar 18; 87():73-81. PubMed ID: 28040599
    [Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.
    Wu D, Liu Z, Wang Y, Zhang Q, Li J, Zhong P, Xie Z, Ji A, Li Y.
    Oxid Med Cell Longev; 2021 Mar 18; 2021():5599997. PubMed ID: 33953830
    [Abstract] [Full Text] [Related]

  • 15. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
    Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, Jois M, Sinclair AJ, Begg DP, Wark JD, Weisinger HS, Weisinger RS.
    Nutr Res; 2009 Nov 18; 29(11):784-93. PubMed ID: 19932867
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
    Ettcheto M, Cano A, Manzine PR, Busquets O, Verdaguer E, Castro-Torres RD, García ML, Beas-Zarate C, Olloquequi J, Auladell C, Folch J, Camins A.
    Mol Neurobiol; 2020 Apr 18; 57(4):1814-1827. PubMed ID: 31838720
    [Abstract] [Full Text] [Related]

  • 18. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
    Yang W, Cao M, Mao X, Wei X, Li X, Chen G, Zhang J, Wang Z, Shi J, Huang H, Yao X, Liu C.
    Nutr Res; 2016 Jun 18; 36(6):586-93. PubMed ID: 27188904
    [Abstract] [Full Text] [Related]

  • 19. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
    Shen S, Wang K, Zhi Y, Shen W, Huang L.
    Cell Cycle; 2020 Nov 18; 19(22):3042-3053. PubMed ID: 33121337
    [Abstract] [Full Text] [Related]

  • 20. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ, Hwang DH.
    Biochem Pharmacol; 2006 Sep 28; 72(7):850-9. PubMed ID: 16890209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.